A trial of a repurposed experimental cancer drug has given parents, physicians, and scientists their first tantalizing evidence that it is possible to affect the course of a rare, fatal disease that causes children to age prematurely and die before reaching adulthood. Mark Kieran, HMS associate professor of pediatrics at Boston Children’s Hospital, led the trial. Leslie Gordon, HMS lecturer on anaesthesia at Boston Children’s Hospital, is also quoted.
Read full article (Subscription required)
